Cutler Group LLC / CA - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
2,400
-63.6%
0.00%
Q3 2022$1,000
-93.8%
6,600
-34.3%
0.00%
-100.0%
Q2 2022$16,000
-89.5%
10,043
-74.0%
0.00%
-87.5%
Q1 2022$153,000
+62.8%
38,590
+76.1%
0.01%
+100.0%
Q4 2021$94,000
-75.6%
21,916
-64.6%
0.00%
-76.5%
Q3 2021$385,000
+151.6%
61,860
+101.5%
0.02%
+142.9%
Q2 2021$153,000
+1076.9%
30,700
+78.5%
0.01%
+600.0%
Q2 2020$13,000
+44.4%
17,200
+251.0%
0.00%0.0%
Q2 2019$9,000
-77.5%
4,900
-22.2%
0.00%
-80.0%
Q1 2019$40,000
+150.0%
6,300
-71.6%
0.01%
+150.0%
Q4 2018$16,000
+33.3%
22,200
+46.1%
0.00%
Q3 2018$12,000
+200.0%
15,200
+985.7%
0.00%
Q2 2018$4,0001,400
+40.0%
0.00%
Q1 2018$01,0000.0%0.00%
Q4 2017$0
-100.0%
1,000
-96.2%
0.00%
-100.0%
Q3 2017$50,000
-71.6%
26,432
-88.5%
0.00%
-66.7%
Q2 2017$176,000
+60.0%
229,492
+89.2%
0.01%
+20.0%
Q1 2017$110,000
-56.7%
121,272
-12.3%
0.01%
-44.4%
Q4 2016$254,000
+206.0%
138,300
+84.2%
0.01%
+125.0%
Q3 2016$83,000
-24.5%
75,100
-14.1%
0.00%
-20.0%
Q2 2016$110,000
-1.8%
87,426
-0.7%
0.01%
-28.6%
Q1 2016$112,000
-56.9%
88,026
-17.4%
0.01%
-50.0%
Q4 2015$260,000106,5260.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders